Jupiter Life Line Hospitals Share Price Today (JLHL)
TODAY IN ONE LINE
JLHL jumped 3.6% on above-average volume (5.2x avg), outperforming Nifty's 0.3% move, supported by recent strong earnings.
With a market cap of ₹10,194.86 Cr., it trades at a P/E of 48.96. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Jupiter Life Line Hospitals flags
Key strengths and potential risks.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 12.0% YoY
- ●Healthy Operating MarginsOPM is structurally strong at 22.9%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
What changed recently?
Recent events, corporate actions, and announcements.
Jupiter Life Line Hospitals Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Jupiter Life Line Hospitals Limited, framed against the sector median so the premium or discount is obvious at a glance.
Jupiter Life Line Hospitals Limited trades at a P/E of 48.96× and P/B of 6.31×.
Valuation
Profitability
Growth
Financial Health
Jupiter Life Line Hospitals Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Jupiter Life Line Hospitals Limited — derived from the live tape, not yesterday's close.
Jupiter Life Line Hospitals Limited last traded at ₹1,554.3 with an intraday range of ₹1,515–₹1,582.9 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1554.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1722.27 | +167.97 | +10.81% |
| R3 | 1654.37 | +100.07 | +6.44% |
| R2 | 1618.63 | +64.33 | +4.14% |
| R1 | 1586.47 | +32.17 | +2.07% |
| PIVOT | 1550.73 | -3.57 | -0.23% |
| CURRENT | 1554.30 | — | — |
| S1 | 1518.57 | -35.73 | -2.30% |
| S2 | 1482.83 | -71.47 | -4.60% |
| S3 | 1450.67 | -103.63 | -6.67% |
| S4 | 1382.77 | -171.53 | -11.04% |
JLHL is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹1515–₹1547.9
Trading Above opening range, showing Bullishness
Jupiter Life Line Hospitals Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Jupiter Life Line Hospitals Limited, switchable between annual and quarterly views, consolidated or standalone.
Jupiter Life Line Hospitals Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹10,194.86 Cr. and reported EPS of ₹29.59.
| Period | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue from Operations | 1,070 | 1,262 | 1,500 |
| Other Income | 26 | 29 | 42 |
| Total Income | 1,095 | 1,290 | 1,542 |
| Cost of Goods Sold (COGS) | 189 | 230 | 287 |
| Gross Profit | 880 | 1,031 | 1,213 |
| +Operating Expenses | 642 | 735 | 869 |
| EBITDA | 238 | 297 | 343 |
| +Non-Operating Expenses | 69 | 68 | 120 |
| Profit Before Tax (PBT) | 195 | 258 | 265 |
| +Tax Expense | 19 | 64 | 66 |
| Total Profit for Period | 177 | 194 | 199 |
| Less: Non-controlling Interests | — | 0 | 0 |
| Net Profit (Owner's PAT) | 177 | 193 | 199 |
| Earnings Per Share (EPS) | 26.94 | 29.47 | 30.33 |
| Diluted Shares Outstanding (Nos.) | 7 | 7 | 7 |
| +Additional Disclosures | 1,091 | 1,262 | 1,560 |
| Sales Growth % | — | 17.96 | 18.88 |
| YoY Sales Growth % | — | 17.96 | 18.88 |
| Employee Cost % | 18 | 17 | 17 |
| Other Cost % | 42 | 41 | 41 |
| OPM % | 22 | 24 | 23 |
| Tax % | 10 | 25 | 25 |
| Profit Growth % | — | 9.39 | 2.95 |
| Gross Margin % | 82.28 | 81.76 | 80.85 |
| EBITDA Margin % | 22.27 | 23.51 | 22.89 |
| Interest Coverage Ratio | 7.43 | 22.70 | 7.83 |
| Ebit | 196 | 240 | 256 |
Jupiter Life Line Hospitals segment analysis: revenue and profit mix.
Disclosed business segments at Jupiter Life Line Hospitals with their share of revenue and profit, switchable between consolidated and standalone reporting.
Jupiter Life Line Hospitals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Jupiter Life Line Hospitals Limited.
Our AI distills the core fundamental drivers supporting Jupiter Life Line Hospitals Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Jupiter Life Line Hospitals Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 17.04% significantly outpaces Apollo 11.1%, demonstrating superior cost control.
ROCE 14.80% exceeds peer benchmarks, indicating highly efficient capital deployment.
Low debt-to-equity ratio 0.0038 provides substantial financial flexibility and stability.
Latest quarterly EPS grew 12% YoY, showing consistent earnings momentum and growth.
Promoter holding 40.91% ensures stable governance and reduces takeover risk substantially.
Key Risks.
High P/E ratio 47.64x suggests potential overvaluation relative to current earnings.
Quarterly profit variance 8.66% indicates recent earnings weakness despite revenue growth.
Dividend yield 0.14% is minimal, offering limited income to shareholders.
Negative free cash flow ₹403.95 Cr in 2025 signals potential liquidity strain.
High capex ₹1,704.95 Cr in 2025 constrains cash available for distributions.
Flip Conditions.
Trim if P/E re-rates above 64. The valuation cushion thins from there.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Income thesis breaks if the dividend is cut or yield falls below 0.07%.
Jupiter Life Line Hospitals Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Jupiter Life Line Hospitals Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Jupiter Life Line Hospitals Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Jupiter Life Line Hospitals Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Jupiter Life Line Hospitals Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Jupiter Life Line Hospitals Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Jupiter Life Line Hospitals Limited stood at 79.9% of traded volume, against a 20-day average of 63.4%.
Jupiter Life Line Hospitals announcements: results, concalls, ratings, M&A.
Filings Jupiter Life Line Hospitals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Jupiter Life Line Hospitals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 111 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Jupiter Life Line Hospitals Limited has informed the Exchange about Certificate 74(5) under SEBI (Depositories and Participants) Regulations, 2018
General Updates
Jupiter Life Line Hospitals Limited has informed the Exchange regarding 'Letter to Shareholders- Weblink of AGM Notice and Annual Report'.
Copy of Newspaper Publication
Jupiter Life Line Hospitals Limited has informed the Exchange about Copy of Newspaper Publication
Trading Window
Jupiter Life Line Hospitals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Shareholders meeting
Notice of the 24th Annual General Meeting of the Company for the Financial Year 2025-26.
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Jupiter Life Line Hospitals dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Jupiter Life Line Hospitals has declared, sequenced by announce and record date.
Jupiter Life Line Hospitals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Jupiter Life Line Hospitals Limited: business, sector, key facts.
What Jupiter Life Line Hospitals Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Jupiter Life Line Hospitals Limited operates in the Hospital industry under the Healthcare sector, listed as NSE: JLHL, BSE: 543980.
Jupiter Life Line Hospitals Limited (JLHL) is a multi-specialty healthcare provider operating in India under the Jupiter brand. Its core business is the delivery of a wide range of medical services across numerous specialties. This comprehensive approach allows them to cater to a diverse patient population requiring various levels of care.
The hospital's services span a considerable spectrum of medical disciplines. These include, but are not limited to, cardiology and cardiac surgery, oncology, orthopedics (including robotic knee replacement and robotic surgery), neurosurgery, gastroenterology, and a comprehensive range of surgical procedures (general, bariatric, minimal access, and HPB surgical gastroenterology). They also offer specialized care in areas such as organ transplantation, interventional radiology, and mental health.
Beyond surgical and procedural interventions, JLHL provides a substantial array of diagnostic and therapeutic services. These include internal medicine, endocrinology and diabetes care, nephrology, neurology, and rheumatology. Support services such as diagnostic imaging, laboratory testing, and rehabilitation are integral components of their holistic patient care model. Additionally, the hospital offers specialized centers, such as breast care, dental care, and a pain clinic.
In addition to its core healthcare operations, JLHL demonstrates diversification through its ownership of a hotel, the Fortune Park Lake City Hotel in Thane. While this venture is distinct from its primary healthcare focus, it potentially contributes to the overall financial stability and operational infrastructure of the company. This diversification strategy may also serve to attract medical tourists or provide convenient accommodation for patients and their families.
Established in 2002 and headquartered in Mumbai, JLHL has positioned itself as a significant player in the Indian healthcare landscape. Its broad service offerings, combined with its multi-specialty approach, aim to provide comprehensive medical care under one roof. The inclusion of the hotel suggests a business model that aims to go beyond pure healthcare provision to create a more integrated patient experience.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Top Gainers TodayScreener
- Other overvalued NSE stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Jupiter Life Line Hospitals Limited (JLHL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Jupiter Life Line Hospitals Limited (JLHL)?
The current share price of Jupiter Life Line Hospitals Limited (JLHL) is ₹1,554.3. Today, the stock has gained by ₹54.50 (3.63%), trading in a range of ₹1,515 to ₹1,582.9. The stock opened at ₹1,528 with a trading volume of 78,545 shares.
02Is Jupiter Life Line Hospitals Limited stock a good investment for long-term?
Jupiter Life Line Hospitals Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,194.86 crores, P/E ratio of 48.96, ROE of 13.10%, and ROCE of 14.80%. The dividend yield stands at 0.14%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Jupiter Life Line Hospitals Limited stock?
The 52-week high price of Jupiter Life Line Hospitals Limited (JLHL) is ₹1,625, while the 52-week low is ₹1,178. Currently trading at ₹1,554.3, the stock is 84.2% away from its 52-week low and 4.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Jupiter Life Line Hospitals Limited stock at the current price?
Whether to buy Jupiter Life Line Hospitals Limited stock at ₹1,554.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 48.96 and P/B ratio of 6.31. Today's performance shows a gain of 3.63%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Jupiter Life Line Hospitals Limited and when is the next dividend?
Jupiter Life Line Hospitals Limited offers a dividend yield of 0.14%, which means for every ₹100 invested at the current price of ₹1,554.3, you can expect to receive approximately ₹0.14 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Jupiter Life Line Hospitals Limited?
Jupiter Life Line Hospitals Limited's key financial metrics include: P/E Ratio: 48.96, P/B Ratio: 6.31, ROE: 13.10%, ROCE: 14.80%, Dividend Yield: 0.14%, EPS: ₹29.59, Book Value: ₹235.5, and Debt-to-Equity: 0.00. The company's market cap stands at ₹10,194.86 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Jupiter Life Line Hospitals Limited stock performing today in the market?
Jupiter Life Line Hospitals Limited stock opened at ₹1,528 and is currently trading at ₹1,554.3, showing a gain of ₹54.50 (3.63%). The intraday high is ₹1,582.9 and low is ₹1,515. The trading volume stands at 78,545 shares, indicating moderate market participation today.
08What is the P/E ratio of Jupiter Life Line Hospitals Limited and what does it indicate?
Jupiter Life Line Hospitals Limited has a Price-to-Earnings (P/E) ratio of 48.96, which means investors are willing to pay ₹48.96 for every ₹1 of earnings. With an EPS of ₹29.59, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Jupiter Life Line Hospitals Limited (JLHL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.